mRNA |
erastin |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
1e-05 |
mRNA |
indisulam |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
1e-05 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0005 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0009 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.001 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.001 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.003 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.003 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.005 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.005 |